Poster Presentation: Cardiovascular
Berecz, Tünde
Heart and Vascular Center, Semmelweis University, Budapest, Hungary
301986878
berecztunde1990@gmail.com
Induced pluripotent stem cell-based modelling of DiGeorge syndrome
Tünde Berecz1,2, Andrea Molnár2, Irén Haltrich3, László Homolya1, Béla Merkely2, Gábor Földes2,4, Ágota Apáti1
1 Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary
2 Heart and Vascular Center, Semmelweis University, Budapest, Hungary
3 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary
4 National Heart and Lung Institute, Imperial College, London, United Kingdom
Poster Presentation: Cardiovascular
Doctoral School: Basic Medicine
Program: Cardiovascular Disorders: Physiology and Medicine of Ischaemic Circulatory Diseases
Supervisor: Dr Gábor Földes
E-mail address of the presenter: berecztunde1990@gmail.com
Pluripotent stem cells (PSC) can be differentiated into derivatives of all three germ layers and develop into all cell types of the human body. Therefore PSCs provide us with the opportunity to study early stages of embryonic development as well as cellular maturation during differentiation. PSCs and their differentiated derivatives can be used for drug and toxicity testing, disease modelling and can be also later applied as potential cell therapy products in regenerative medicine. PSCs can be derived from embryonic state (ESC: embryonic stem cell) or generated by reprogramming differentiated somatic cells into pluripotent state (iPSC: induced pluripotent stem cell).
Understanding underlying pathological mechanisms in certain diseases is limited by currently available model systems. Our aim is to investigate in vitro cellular phenotypes in complex diseases such as DiGeorge syndrome, which is genetically determined and affects several organ systems (i.e. cardiovascular, nervous and immune systems). DiGeorge syndrome is caused by the deletion of the 22q11.2 chromosome region which affects only one allele but the hemizygous presence of the genes is not sufficient for the healthy phenotype. For modelling this disease we generated iPSCs from blood samples of a mother and her daughter (both suffering from disease) as well as from healthy spouse as control. Reprogramming of peripheral blood mononuclear cells to pluripotent state was performed by the expression of four transcription factors (Oct3/4, Sox2, Klf4 and c-Myc) using Sendai virus vector (SeV). SeV is a single stranded RNA virus which does not integrate into the host’s genome. iPSCs are being differentiated into cell types relevant to the disease by mimicking the in vivo developmental program, thus we perform cardiac, endothelial and neural differentiation. During this process we compare phenotypes of disease affected and control cells.
P66
Szabad
nem rendelkezett róla
1099
Tünde Berecz1,2, Andrea Molnár2, Irén Haltrich3, László Homolya1, Béla Merkely2, Gábor Földes2,4, Ágota Apáti1
1 Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary
2 Heart and Vascular Center, Semmelweis University, Budapest, Hungary
3 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary
4 National Heart and Lung Institute, Imperial College, London, United Kingdom